In various reports, a high frequency of CD8+ tumor-infiltrating lymphocytes [15] or a low frequency of MDSCs [16] or FOXP3+ Tregs [17] in tumors was associated with longer survival in the targeted tumor types. This evidence concerns the gene CD8A and neoplasm.